With $5.7 billion in CHIPS Act funding flowing to Intel and more investments planned, these companies are riding a wave of unprecedented government support for domestic semiconductor production.
America's push for semiconductor independence isn't just economic policy - it's a national security imperative that could drive sustained investment and growth across the entire supply chain.
This represents the largest government intervention in the semiconductor industry in decades, potentially creating a multi-year tailwind for companies positioned in America's chip manufacturing ecosystem.
Summary of the basket's total market capitalisation and breakdown by constituent market caps.
INTC: $178.03B
TSM: $1.23T
ASML: $400.56B
The $5.7 billion CHIPS Act funding to Intel represents a pivotal moment for American semiconductor independence. This government-backed initiative signals a long-term commitment to onshoring critical technology production, creating a favourable investment environment across the entire domestic semiconductor supply chain from chip designers to equipment manufacturers.
This group includes companies positioned to benefit from America's strategic push towards semiconductor self-sufficiency. The government's direct equity stake in Intel sets a precedent for public-private partnerships in critical technology sectors, potentially influencing future investments and creating sustained growth opportunities across the industry.
These companies were handpicked by professional analysts as key players in America's semiconductor resurgence. From pure-play foundries to equipment suppliers and materials providers, each represents a different aspect of the domestic chip manufacturing ecosystem that stands to benefit from this historic government investment.
Intel has secured $5.7 billion in government funding under the CHIPS Act, a move aimed at bolstering U.S. semiconductor manufacturing. This investment signals a broader push to onshore critical technology production, creating a favorable environment for companies across the domestic semiconductor supply chain.
+5
Here are a few of the assets in this group. Create an account to unlock the full list.
Join Nemo FREE today and unlock every stock
Es dauert nur 60 Sekunden.
9 von 14 Werten dieser Gruppe werden von professionellen Analysten mit „Kaufen“ bewertet.
Erfahren Sie alles über diesen Aktienkorb. Lesen Sie unseren ausführlichen Artikel zu seinen Risiken und seinem Potenzial.
Vollständige Analyse lesen
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Part of Exinity Group 2015, serving over a million customers globally.
Earn 6% AER on uninvested cash with daily interest payments.
Gilead Sciences has secured FDA approval for a new once-daily HIV combination pill, streamlining therapy for millions of suppressed patients. This regulatory milestone spotlights investment opportunities in pioneering biopharmaceutical companies and drug delivery developers focused on advanced antiviral treatments.
Disney is suing the FCC to block an early license review of its ABC stations, arguing the move is politically motivated retaliation against its news coverage. This unprecedented legal battle highlights the growing regulatory risks for traditional broadcasters and underscores the structural advantages of unregulated digital streaming platforms.
SK Hynix has unveiled a record-breaking 40 trillion won share buyback fueled by soaring demand for its AI memory chips. This historic capital return creates a compelling investment theme centered on high-bandwidth memory producers and the specialized equipment manufacturers that enable their advanced production.
